DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Defense DEF

Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion (RSDL).

Contacted: Food & Drug Administration (FDA); Defense Threat Reduction Agency (DTRA); White House Office; Homeland Security, Dept of (DHS); Centers For Disease Control & Prevention (CDC); Air Force, Dept of; Health & Human Services, Dept of (HHS); SENATE; Defense Logistics Agency; Defense, Dept of (DOD); Army, Dept of (Other); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Joint Chiefs of Staff

Homeland Security HOM

Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Defense Threat Reduction Agency (DTRA); HOUSE OF REPRESENTATIVES; Army, Dept of (Other); Defense Logistics Agency; Health & Human Services, Dept of (HHS); Joint Chiefs of Staff; Natl Institutes of Health (NIH); SENATE; Defense, Dept of (DOD); Air Force, Dept of; White House Office

Bills named: H.R. 1300 (114th), S. 1915 (114th), H.R. 3299 (114th)